Announcement

Collapse
No announcement yet.

Medexus gets Health Canada nod to market tumor imaging material Gleolan for neurosurgery

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Medexus gets Health Canada nod to market tumor imaging material Gleolan for neurosurgery

    Medexus gets Health Canada nod to market tumor imaging material Gleolan for neurosurgery

  • #2
    Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)

    Gleolan is finally approved in Canada. It has been standard of care in Europe for many years before it was approved in the USA 3 years ago. According to the article cited , it doubles the chance of a complete resection, and doubles the 6 month progression free survival rate. This is a dye used at the time of surgery to make it easier for the surgeon to identify where the tumor is.

    Comment

    Working...
    X